January 23rd, 2023 Ubiquigent collaborates with University of Glasgow on translational structural biology to accelerate drug discovery within the (de)ubiquitylation field
October 31st, 2022 Ubiquigent obtains exclusive license for UbiSite® technology to strengthen its specialist drug discovery services